News|Articles|October 2, 2002

Pharmaceutical Technology-10-02-2002
Volume 26
Issue 10

Will CROs Find Opportunity in a Reinvigorated European R&D Sector? Outsourcing Outlook

The European Union is attempting to reform its current business environment in hopes of restoring its role in the lobal R&D sector.

External Link - article-36193.pdf

Articles in this issue

almost 24 years ago

Article

FDA Launches Major Review of CGMPs

almost 24 years ago

Article

Understanding Pharmaceutical Flows

almost 24 years ago

Article

An Overview of the Validation Approach for Moist Heat Sterilization, Part II

almost 24 years ago

Article

Cyclodextrins as Sustained-Release Carriers

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Bristol Myers Squibb announced plans to expand its computing infrastructure collaboration with NVIDIA

Everything to Know about BMS & NVidia’s AI Supercomputer

ByZachary Zubulake

July 20th 2026

Midyear 2026 Check-In: Agentic AI Cuts Deviation Investigations by 50%

ByMegha Sinha,Zachary Zubulake

July 17th 2026

FDA concept. Concept of the Food and Drug Administration. Magnifier glass, folder and clock | Image credit: © Sviatlana - © Sviatlana-stock.adobe.com

Using Risk-Based Quality Frameworks to Fast-Track Biopharma Development: A Q&A with Abzena’s Jeffrey C. Mocny and Cellares’ Anna McMahon

ByFeliza Mirasol,Jeffrey C. Mocny,Anna McMahon

July 15th 2026

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS) | © Tada Images - stock.adobe.com (521699065)

FDA Activity Round Up – July 2026

ByZachary Zubulake

July 15th 2026

test tube ampoule syringe flag europe doctor vaccine medicine | Image Credit: ©NataliAlba -stock.adobe.com

EMA and EU Innovation Agency Deepen Ties to Speed Up Drug Development

BySusan Haigney

July 15th 2026

Will CROs Find Opportunity in a Reinvigorated European R&D Sector? Outsourcing Outlook

Articles in this issue

Related Content

Everything to Know about BMS & NVidia’s AI Supercomputer

Midyear 2026 Check-In: Agentic AI Cuts Deviation Investigations by 50%

Using Risk-Based Quality Frameworks to Fast-Track Biopharma Development: A Q&A with Abzena’s Jeffrey C. Mocny and Cellares’ Anna McMahon

FDA Activity Round Up – July 2026

EMA and EU Innovation Agency Deepen Ties to Speed Up Drug Development

Trending on Pharmaceutical Technology

Everything to Know about BMS & NVidia’s AI Supercomputer

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

Can AI Fix Pharma's Last-Mile Delivery Blind Spot?

The Implications of the FDA’s New Finalized Guidance Documents

Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory